View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EssilorLuxottica and Burberry announce licensing partnership renewal

EssilorLuxottica and Burberry announce licensing partnership renewal EssilorLuxottica and Burberryannounce licensing partnership renewal Paris, France and London, United Kingdom (18 December 2025) – EssilorLuxottica and Burberry today announced the renewal of their licensing agreement for the development, production and global distribution of eyewear under the Burberry brand. The existing agreement, expiring on December 31, 2025, has been extended through December 31, 2035. Building on a shared legacy of creativity, craftsmanship and innovation, the renewal reinforces a long-standing pa...

 PRESS RELEASE

EssilorLuxottica et Burberry renouvellent leur accord de licence

EssilorLuxottica et Burberry renouvellent leur accord de licence EssilorLuxottica et Burberryrenouvellent leur accord de licence Paris, France et Londres, Royaume-Uni (18 décembre 2025) – EssilorLuxottica et Burberry ont annoncé aujourd’hui le renouvellement de leur accord de licence pour la conception, la production et la distribution mondiale de lunettes sous la marque Burberry. L’accord en vigueur, venant à échéance le 31 décembre 2025, a été prolongé jusqu’au 31 décembre 2035. S'appuyant sur une culture partagée de créativité, de savoir-faire et d'innovation, ce renouvellement vient...

 PRESS RELEASE

EssilorLuxottica e Burberry rinnovano l’accordo di licenza

EssilorLuxottica e Burberry rinnovano l’accordo di licenza EssilorLuxottica e Burberry rinnovano l’accordo di licenza Parigi, Francia e Londra, Regno Unito (18 dicembre 2025) – EssilorLuxottica e Burberry annunciano il rinnovo dell’accordo di licenza per lo sviluppo, la produzione e la distribuzione a livello globale di occhiali a marchio Burberry. L’accordo in essere, con scadenza prevista il 31 dicembre 2025, viene rinnovato fino al 31 dicembre 2035. Con una tradizione condivisa di creatività, artigianalità e innovazione, il rinnovo rafforza una collaborazione avviata tra le due socie...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 15/12/2025

Eroski : bons résultats T3, sans surprise|Altice France aurait reçu plusieurs offres allant de 4,8 à 5,6 mds EUR pour Netco (La Tribune)|

Carole Braudeau
  • Carole Braudeau

Credit Morning 12/15/2025

Eroski: good set of Q3 results, unsurprisingly|Altice France reportedly gets several bids between € 4.8bn to € 5.6bn for Netco (La Tribune)|

Geoffroy Michalet
  • Geoffroy Michalet
Geoffroy Michalet
  • Geoffroy Michalet
Ana Arjona-Martinez ... (+2)
  • Ana Arjona-Martinez
  • Yan Derocles
 PRESS RELEASE

EssilorLuxottica to acquire Signifeye, further growing its ophthalmolo...

EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint EssilorLuxottica to acquire Signifeye,further growing its ophthalmology clinics footprint Paris, France (12 December 2025) – EssilorLuxottica announced today the acquisition of Signifeye, a leading Belgian ophthalmology platform delivering top-tier patient care across 15 eye centers and clinics in the Flanders region. The transaction comes soon after the recent acquisition of Optegra, a fast-growing and highly integrated ophthalmology platform in Europe operating over 70 clinics in the UK, Czech Re...

 PRESS RELEASE

EssilorLuxottica va acquérir Signifeye, poursuivant l’extension de son...

EssilorLuxottica va acquérir Signifeye, poursuivant l’extension de son réseau de cliniques ophtalmologiques EssilorLuxottica va acquérir Signifeye,poursuivant l’extension de son réseau de cliniques ophtalmologiques Paris, France (12 décembre 2025) – EssilorLuxottica a annoncé aujourd’hui l’acquisition de Signifeye, une plateforme d’ophtalmologie belge de premier plan qui propose aux patients des prestations médicales de haut niveau grâce à 15 cliniques et centres de l’œil situés en Flandre. Cette transaction fait suite à la récente acquisition d’Optegra, une plateforme européenne d'ophta...

 PRESS RELEASE

EssilorLuxottica acquisisce Signifeye e continua ad espandere la sua r...

EssilorLuxottica acquisisce Signifeye e continua ad espandere la sua rete di cliniche oftalmiche EssilorLuxottica acquisisce Signifeyee continua ad espandere la sua rete di cliniche oftalmiche Parigi, Francia (12 dicembre 2025) – EssilorLuxottica annuncia l’acquisizione di Signifeye, una delle principali piattaforme oftalmiche belghe che offre percorsi di cura di eccellenza attraverso 15 cliniche oftalmiche e centri diagnostici nella regione delle Fiandre. L’operazione fa seguito alla recente acquisizione di Optegra, una piattaforma oftalmica europea in forte espansione e perfettamente...

 PRESS RELEASE

WENDEL: Wendel Investor Day

WENDEL: Wendel Investor Day Wendel's transformation: two powerful value creation engines expected to generate more than €7 billion in cash flow by end 2030 and to return at least €1.6 billion to shareholders  Cancellation of 3.8% of treasury shares and launch of a share buyback representing 9% of the share capital in 2026 In less than three years, Wendel has carried out a major strategic transformation, evolving from a traditional investment holding company into a global investment firm focused on creating value through controlled private assets, serving both its clients and shareholders,...

 PRESS RELEASE

WENDEL : Journée Investisseurs de Wendel

WENDEL : Journée Investisseurs de Wendel  Transformation de Wendel : deux moteurs puissants de création de valeur devant générer plus de 7 milliards d’euros de trésorerie d’ici fin 2030 et retourner au moins 1,6 milliard aux actionnaires Annulation de 3,8% du capital auto-détenu et lancement d'un rachat d’actions représentant 9% du capital sur l'année 2026 En moins de trois ans, Wendel a opéré une transformation stratégique majeure, passant d’une holding d’investissement traditionnelle à une société d’investissement globale, focalisée sur la création de valeur via des actifs privés cont...

Ana Arjona-Martinez ... (+2)
  • Ana Arjona-Martinez
  • Yan Derocles
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch